{"gene":"DRD4","run_date":"2026-06-09T23:54:42","timeline":{"discoveries":[{"year":1993,"finding":"The DRD4 gene contains a hypervariable segment within the third cytoplasmic loop of the protein, consisting of varying numbers of imperfect 48-bp direct repeats (2–10 repeat units) in exon 3. Alleles vary in both repeat number and sequence, producing 18 different predicted amino acid sequences, making this one of the most variable functional proteins described.","method":"PCR amplification and sequence analysis of 178 unrelated chromosomes; pharmacological characterization of allelic variants","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct DNA sequencing with pharmacological characterization, replicated across large population sample","pmids":["8353495"],"is_preprint":false},{"year":1999,"finding":"A -521C>T polymorphism in the 5'-promoter region of DRD4 was identified; transient expression assays showed that the T allele reduces DRD4 transcriptional efficiency by approximately 40% compared with the C allele.","method":"Identification of novel SNP by sequencing; transient expression (reporter) assay measuring transcriptional efficiency","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro transcriptional assay in a single study, not independently replicated in this corpus","pmids":["10329380"],"is_preprint":false},{"year":2009,"finding":"Pineal Drd4 expression shows a >100-fold circadian rhythm under photoneural control; the gene is expressed predominantly in pinealocytes and retina. Unlike most rhythmically expressed pineal genes controlled solely by adrenergic/cAMP signaling, Drd4 expression additionally requires thyroid hormone.","method":"mRNA quantification across tissues and time points in rat; pharmacological and photoneural manipulation (adrenergic signaling blockade, thyroid hormone manipulation)","journal":"Molecular and cellular endocrinology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo rat model with multiple pharmacological manipulations, single lab","pmids":["19482058"],"is_preprint":false},{"year":2021,"finding":"DRD4 activation (by agonist PD168077) in isolated rat hearts and cardiomyocytes subjected to ischemia/reperfusion injury reduced apoptosis, improved cardiac function, and increased membrane GLUT4 localization (without changing total GLUT4 protein). This protective effect was dependent on PI3K/AKT pathway activation; PI3K inhibitor (Wortmannin) blocked GLUT4 membrane translocation and reversed the cardioprotection.","method":"Langendorff ex vivo perfused rat heart I/R model; in vitro cardiomyocyte A/R model; DRD4 agonist (PD168077); Western blot for PI3K/AKT phosphorylation and GLUT4 localization; TUNEL staining; flow cytometry; PI3K inhibitor epistasis","journal":"Frontiers in pharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (ex vivo, in vitro, pharmacological epistasis), single lab","pmids":["33584304"],"is_preprint":false},{"year":2024,"finding":"DRD4 is decreased in kidneys during AKI (IRI or cisplatin model). DRD4 suppresses oxidative stress-induced AKI by downregulating ISG15 expression, which in turn suppresses NOX4 ISGylation; reduced ISGylation enhances ubiquitination and proteasomal degradation of NOX4, decreasing ROS production and mitochondrial damage. DRD4 overexpression ameliorates apoptosis in HK-2 cells.","method":"In vivo mouse IRI and cisplatin AKI models; in vitro HK-2 cell hypoxia/reoxygenation; transcriptome sequencing; Western blot for ISG15, NOX4, ubiquitination/ISGylation; ROS assays; DRD4 overexpression/knockdown","journal":"Redox biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (in vivo, in vitro, transcriptomics, biochemical pathway dissection), single lab","pmids":["38354631"],"is_preprint":false},{"year":2020,"finding":"Meta-analytic and bioinformatics analysis established that the DRD4 4-repeat allele leads to higher receptor expression and increased sensitivity to dopamine compared with the 7-repeat allele, consistent with the 4R allele being protective and 7R being a risk factor for ADHD in European-Caucasian populations. The 7R allele was also linked to poorer methylphenidate efficacy.","method":"Meta-analysis of >3000 cases and >16,000 controls; bioinformatics analysis of receptor expression data comparing 4R vs. 7R allele functional differences","journal":"Translational psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — large meta-analysis integrating published functional and clinical data, but no new in vitro/in vivo mechanistic experiment","pmids":["32075956"],"is_preprint":false},{"year":2010,"finding":"DRD4 mRNA expression is significantly elevated in peripheral blood lymphocytes of both musicians and individuals with autistic spectrum disorder (ASD) compared to healthy controls, whereas DRD3 mRNA expression did not differ between groups.","method":"mRNA expression quantification by RT-PCR from peripheral blood lymphocytes in three groups (controls, musicians, ASD); ANOVA with post-hoc analysis","journal":"Neuro endocrinology letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single method (mRNA quantification in blood), no functional follow-up","pmids":["20150884"],"is_preprint":false},{"year":2019,"finding":"In TMZ-resistant glioblastoma cells, DRD4 expression is upregulated alongside Akt, mTOR, β-catenin, CDK6, NF-κB, and Erk1/2. Treatment with the novel compound LCC-09 downregulated DRD4 and these downstream signaling molecules, suppressed GSC stemness traits, and was associated with re-expression of tumor suppressor miR-34a, both in vitro and in vivo.","method":"GBM cell lines (U87MG, D54MG); Western blot for DRD4 and pathway markers; neurosphere formation; ALDH activity assay; in vivo xenograft model; miR-34a expression analysis","journal":"Cancers","confidence":"Low","confidence_rationale":"Tier 3 / Weak — DRD4 pathway placement is correlative/pharmacological (no DRD4-specific genetic manipulation), single lab","pmids":["31561595"],"is_preprint":false}],"current_model":"DRD4 is a G protein-coupled dopamine receptor whose third cytoplasmic loop encodes a highly polymorphic 48-bp VNTR (2–10 repeats) that alters receptor amino acid sequence and function (with the 4-repeat allele conferring higher receptor expression and dopamine sensitivity than the 7-repeat allele); its promoter -521C>T SNP regulates transcriptional efficiency (~40% reduction for T allele); in the pineal gland its expression is driven by both adrenergic/cAMP and thyroid hormone signals in a circadian fashion; in the kidney DRD4 protects against acute injury by suppressing the ISG15–NOX4 ISGylation axis to reduce oxidative stress and apoptosis; and in the heart DRD4 activation promotes GLUT4 membrane translocation via PI3K/AKT signaling to confer cardioprotection against ischemia/reperfusion injury."},"narrative":{"mechanistic_narrative":"DRD4 is a G protein-coupled dopamine receptor distinguished by an extraordinarily polymorphic third cytoplasmic loop, where exon 3 carries a hypervariable 48-bp VNTR (2–10 repeat units) that generates at least 18 distinct receptor amino acid sequences, making it one of the most variable functional human proteins described [PMID:8353495]. This coding variation has functional consequences: the 4-repeat allele confers higher receptor expression and greater dopamine sensitivity than the 7-repeat allele, with allelic differences linked to ADHD risk and methylphenidate response in European-Caucasian populations [PMID:32075956]. Receptor abundance is further tuned at the transcriptional level by a -521C>T promoter polymorphism, where the T allele reduces transcriptional efficiency by roughly 40% [PMID:10329380]. DRD4 expression is itself dynamically regulated: in the pineal gland it shows a >100-fold circadian rhythm under photoneural control and, unusually, requires thyroid hormone in addition to the adrenergic/cAMP signaling that drives most rhythmic pineal genes [PMID:19482058]. Beyond the nervous system, DRD4 signaling is cytoprotective in peripheral tissues: in ischemic/reperfused heart, agonist activation drives GLUT4 membrane translocation through PI3K/AKT signaling to limit cardiomyocyte apoptosis [PMID:33584304], and in the kidney it suppresses oxidative-stress-induced acute injury by downregulating ISG15 to reduce NOX4 ISGylation, thereby promoting NOX4 ubiquitination and proteasomal degradation and lowering ROS [PMID:38354631].","teleology":[{"year":1993,"claim":"Established that DRD4 harbors an unprecedented coding polymorphism, defining the molecular basis for functional receptor heterogeneity in the population.","evidence":"PCR amplification and sequencing of 178 chromosomes with pharmacological characterization of allelic variants","pmids":["8353495"],"confidence":"High","gaps":["Did not establish how individual repeat numbers alter G-protein coupling or downstream signaling output","Functional consequences of specific sequence variants not resolved"]},{"year":1999,"claim":"Identified a promoter SNP controlling DRD4 transcription, showing receptor dosage is regulated upstream of coding variation.","evidence":"Novel SNP identification by sequencing and transient reporter expression assay","pmids":["10329380"],"confidence":"Medium","gaps":["In vitro reporter assay not replicated in this corpus","Transcription factor binding mediating the -521C>T effect not identified"]},{"year":2009,"claim":"Revealed dual hormonal control of DRD4 expression, distinguishing it from canonically cAMP-driven pineal genes by adding a thyroid hormone requirement.","evidence":"mRNA quantification across rat tissues/timepoints with adrenergic blockade and thyroid hormone manipulation","pmids":["19482058"],"confidence":"Medium","gaps":["Molecular mechanism linking thyroid hormone to Drd4 transcription not defined","Functional role of circadian DRD4 in pinealocytes/retina not established"]},{"year":2010,"claim":"Correlated peripheral DRD4 expression with behavioral phenotypes, but without mechanistic linkage.","evidence":"RT-PCR mRNA quantification in blood lymphocytes from controls, musicians, and ASD individuals","pmids":["20150884"],"confidence":"Low","gaps":["Single method (blood mRNA) with no functional follow-up","No causal link between lymphocyte DRD4 levels and phenotype"]},{"year":2019,"claim":"Placed DRD4 in a glioblastoma stemness signaling network, though only by correlation.","evidence":"GBM cell lines and xenograft with Western blot, neurosphere and ALDH assays following LCC-09 treatment","pmids":["31561595"],"confidence":"Low","gaps":["DRD4 pathway placement is pharmacological/correlative without DRD4-specific genetic manipulation","Direct role of DRD4 versus co-regulated effectors not separated"]},{"year":2020,"claim":"Quantified the functional difference between 4R and 7R alleles, connecting receptor expression/dopamine sensitivity to disease risk and drug response.","evidence":"Meta-analysis of >3000 cases/>16000 controls with bioinformatic comparison of allele expression","pmids":["32075956"],"confidence":"Medium","gaps":["No new in vitro/in vivo mechanistic experiment","Causal molecular basis for differential dopamine sensitivity not directly tested"]},{"year":2021,"claim":"Defined a cardioprotective signaling output for DRD4, linking receptor activation to glucose transporter trafficking via PI3K/AKT.","evidence":"Langendorff ex vivo heart and cardiomyocyte I/R models with PD168077 agonist and Wortmannin epistasis, GLUT4 and phospho-AKT Western blots","pmids":["33584304"],"confidence":"Medium","gaps":["Single lab; G-protein coupling upstream of PI3K not delineated","In vivo cardioprotection in whole animals not tested"]},{"year":2024,"claim":"Established a renal cytoprotective mechanism, mapping DRD4 to suppression of the ISG15–NOX4 ISGylation axis and consequent ROS reduction.","evidence":"Mouse IRI/cisplatin AKI and HK-2 hypoxia/reoxygenation models with transcriptomics, ISGylation/ubiquitination Western blots, ROS assays, DRD4 overexpression/knockdown","pmids":["38354631"],"confidence":"Medium","gaps":["Mechanism linking DRD4 signaling to ISG15 downregulation not resolved","Single lab; receptor-proximal signaling steps undefined"]},{"year":null,"claim":"How the coding VNTR and promoter variants mechanistically translate into differential downstream signaling, and whether the cardiac and renal cytoprotective pathways generalize, remains open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural/biochemical link between repeat number and G-protein coupling efficiency","Receptor-proximal signaling steps in heart and kidney not defined","Common molecular logic across tissues not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,3]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3]}],"pathway":[],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P21917","full_name":"D(4) dopamine receptor","aliases":["D(2C) dopamine receptor","Dopamine D4 receptor"],"length_aa":419,"mass_kda":43.9,"function":"Dopamine receptor responsible for neuronal signaling in the mesolimbic system of the brain, an area of the brain that regulates emotion and complex behavior. Activated by dopamine, but also by epinephrine and norepinephrine, and by numerous synthetic agonists and drugs (PubMed:16423344, PubMed:27659709, PubMed:29051383, PubMed:9003072). Agonist binding triggers signaling via G proteins that inhibit adenylyl cyclase (PubMed:16423344, PubMed:27659709, PubMed:29051383, PubMed:7512953, PubMed:7643093). Modulates the circadian rhythm of contrast sensitivity by regulating the rhythmic expression of NPAS2 in the retinal ganglion cells (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P21917/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DRD4","classification":"Not Classified","n_dependent_lines":3,"n_total_lines":1208,"dependency_fraction":0.0024834437086092716},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DRD4","total_profiled":1310},"omim":[{"mim_id":"616417","title":"ADHESION G PROTEIN-COUPLED RECEPTOR L3; ADGRL3","url":"https://www.omim.org/entry/616417"},{"mim_id":"614522","title":"KELCH-LIKE 12; KLHL12","url":"https://www.omim.org/entry/614522"},{"mim_id":"609445","title":"RELAXIN/INSULIN-LIKE FAMILY PEPTIDE RECEPTOR 3; RXFP3","url":"https://www.omim.org/entry/609445"},{"mim_id":"609312","title":"DOPAMINE BETA-HYDROXYLASE, PLASMA; DBH","url":"https://www.omim.org/entry/609312"},{"mim_id":"608516","title":"MAJOR DEPRESSIVE DISORDER; MDD","url":"https://www.omim.org/entry/608516"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Plasma membrane","reliability":"Uncertain"},{"location":"Centrosome","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in many","driving_tissues":[],"url":"https://www.proteinatlas.org/search/DRD4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P21917","domains":[{"cath_id":"1.20.1070.10","chopping":"30-231_341-419","consensus_level":"medium","plddt":91.1619,"start":30,"end":419}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P21917","model_url":"https://alphafold.ebi.ac.uk/files/AF-P21917-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P21917-F1-predicted_aligned_error_v6.png","plddt_mean":77.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DRD4","jax_strain_url":"https://www.jax.org/strain/search?query=DRD4"},"sequence":{"accession":"P21917","fasta_url":"https://rest.uniprot.org/uniprotkb/P21917.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P21917/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P21917"}},"corpus_meta":[{"pmid":"8353495","id":"PMC_8353495","title":"A hypervariable segment in the human dopamine receptor D4 (DRD4) gene.","date":"1993","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8353495","citation_count":490,"is_preprint":false},{"pmid":"9491811","id":"PMC_9491811","title":"Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9491811","citation_count":276,"is_preprint":false},{"pmid":"15077199","id":"PMC_15077199","title":"The genetic architecture of selection at the human dopamine receptor D4 (DRD4) gene locus.","date":"2004","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15077199","citation_count":238,"is_preprint":false},{"pmid":"17574217","id":"PMC_17574217","title":"Association of the dopamine D4 receptor (DRD4) gene and approach-related personality traits: meta-analysis and new data.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17574217","citation_count":208,"is_preprint":false},{"pmid":"9774775","id":"PMC_9774775","title":"Dopamine DRD4 receptor polymorphism and attention deficit hyperactivity disorder.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9774775","citation_count":166,"is_preprint":false},{"pmid":"17525955","id":"PMC_17525955","title":"Analysis of DRD4 and DAT polymorphisms and behavioral inhibition in healthy adults: implications for impulsivity.","date":"2008","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17525955","citation_count":164,"is_preprint":false},{"pmid":"10329380","id":"PMC_10329380","title":"A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10329380","citation_count":137,"is_preprint":false},{"pmid":"12210280","id":"PMC_12210280","title":"DRD4 and novelty seeking: results of meta-analyses.","date":"2002","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12210280","citation_count":133,"is_preprint":false},{"pmid":"9345090","id":"PMC_9345090","title":"D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects.","date":"1997","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9345090","citation_count":129,"is_preprint":false},{"pmid":"18540916","id":"PMC_18540916","title":"Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes.","date":"2008","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/18540916","citation_count":120,"is_preprint":false},{"pmid":"17472912","id":"PMC_17472912","title":"Drd4 gene polymorphisms are associated with personality variation in a passerine bird.","date":"2007","source":"Proceedings. Biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/17472912","citation_count":106,"is_preprint":false},{"pmid":"11583250","id":"PMC_11583250","title":"The association of the dopamine D4 receptor gene (DRD4) and the serotonin transporter promoter gene (5-HTTLPR) with temperament in 12-month-old infants.","date":"2001","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/11583250","citation_count":104,"is_preprint":false},{"pmid":"11126393","id":"PMC_11126393","title":"Dopamine D4 receptor (DRD4) gene polymorphism is associated with attachment disorganization in infants.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11126393","citation_count":98,"is_preprint":false},{"pmid":"7944879","id":"PMC_7944879","title":"Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine.","date":"1994","source":"Archives of general psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/7944879","citation_count":91,"is_preprint":false},{"pmid":"17178609","id":"PMC_17178609","title":"DRD4 7-repeat polymorphism moderates the association between maternal unresolved loss or trauma and infant disorganization.","date":"2006","source":"Attachment & human development","url":"https://pubmed.ncbi.nlm.nih.gov/17178609","citation_count":87,"is_preprint":false},{"pmid":"15274053","id":"PMC_15274053","title":"Association analysis of the DRD4 and COMT genes in methamphetamine abuse.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15274053","citation_count":83,"is_preprint":false},{"pmid":"21873960","id":"PMC_21873960","title":"Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders.","date":"2011","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/21873960","citation_count":81,"is_preprint":false},{"pmid":"15909295","id":"PMC_15909295","title":"DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15909295","citation_count":80,"is_preprint":false},{"pmid":"16751296","id":"PMC_16751296","title":"DRD4 and DAT1 polymorphisms modulate human gamma band responses.","date":"2006","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/16751296","citation_count":79,"is_preprint":false},{"pmid":"10898897","id":"PMC_10898897","title":"No association of the dopamine DRD4 receptor (DRD4) gene polymorphism with attention deficit hyperactivity disorder (ADHD) in the Irish population.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10898897","citation_count":76,"is_preprint":false},{"pmid":"17587443","id":"PMC_17587443","title":"A gene x gene interaction between DRD2 and DRD4 is associated with conduct disorder and antisocial behavior in males.","date":"2007","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/17587443","citation_count":72,"is_preprint":false},{"pmid":"17611740","id":"PMC_17611740","title":"DRD4 VNTR polymorphism is associated with transient fMRI-BOLD responses to smoking cues.","date":"2007","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17611740","citation_count":68,"is_preprint":false},{"pmid":"20070517","id":"PMC_20070517","title":"Association between DRD4 gene polymorphism and personality variation in great tits: a test across four wild populations.","date":"2010","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/20070517","citation_count":68,"is_preprint":false},{"pmid":"10206238","id":"PMC_10206238","title":"Allelic variants of dopamine receptor D4 (DRD4) and serotonin receptor 5HT2c (HTR2c) and temperament factors: replication tests.","date":"1999","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10206238","citation_count":67,"is_preprint":false},{"pmid":"16619053","id":"PMC_16619053","title":"Polymorphisms in the dopamine D4 receptor gene (DRD4) contribute to individual differences in human sexual behavior: desire, arousal and sexual function.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16619053","citation_count":67,"is_preprint":false},{"pmid":"7831304","id":"PMC_7831304","title":"Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species.","date":"1995","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/7831304","citation_count":64,"is_preprint":false},{"pmid":"17167341","id":"PMC_17167341","title":"The association of DRD4 and novelty seeking is found in a nonhuman primate model.","date":"2007","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17167341","citation_count":64,"is_preprint":false},{"pmid":"24747168","id":"PMC_24747168","title":"The dopamine D4 receptor gene (DRD4) moderates cultural difference in independent versus interdependent social orientation.","date":"2014","source":"Psychological science","url":"https://pubmed.ncbi.nlm.nih.gov/24747168","citation_count":63,"is_preprint":false},{"pmid":"15578612","id":"PMC_15578612","title":"Dopamine receptor D4 (DRD4) gene in Han Chinese children with attention-deficit/hyperactivity disorder (ADHD): increased prevalence of the 2-repeat allele.","date":"2005","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15578612","citation_count":63,"is_preprint":false},{"pmid":"16319504","id":"PMC_16319504","title":"Temperament and character in mood disorders: influence of DRD4, SERTPR, TPH and MAO-A polymorphisms.","date":"2005","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/16319504","citation_count":62,"is_preprint":false},{"pmid":"22848508","id":"PMC_22848508","title":"Dopamine genes (DRD2/ANKK1-TaqA1 and DRD4-7R) and executive function: their interaction with obesity.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22848508","citation_count":61,"is_preprint":false},{"pmid":"17239353","id":"PMC_17239353","title":"Interactive effects of a DRD4 polymorphism, lead, and sex on executive functions in children.","date":"2007","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17239353","citation_count":58,"is_preprint":false},{"pmid":"12497615","id":"PMC_12497615","title":"Association between the dopamine receptor D4 (DRD4) gene and obsessive-compulsive disorder.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12497615","citation_count":56,"is_preprint":false},{"pmid":"10898895","id":"PMC_10898895","title":"A haplotype relative risk study of the dopamine D4 receptor (DRD4) exon III repeat polymorphism and attention deficit hyperactivity disorder (ADHD).","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10898895","citation_count":56,"is_preprint":false},{"pmid":"7573171","id":"PMC_7573171","title":"DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls.","date":"1995","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/7573171","citation_count":53,"is_preprint":false},{"pmid":"17922530","id":"PMC_17922530","title":"A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa.","date":"2008","source":"The International journal of eating disorders","url":"https://pubmed.ncbi.nlm.nih.gov/17922530","citation_count":52,"is_preprint":false},{"pmid":"20203140","id":"PMC_20203140","title":"Gender-specific expression of the DRD4 gene on adolescent delinquency, anger and thrill seeking.","date":"2010","source":"Social cognitive and affective neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20203140","citation_count":52,"is_preprint":false},{"pmid":"15389763","id":"PMC_15389763","title":"Phenotype studies of the DRD4 gene polymorphisms in ADHD: association with oppositional defiant disorder and positive family history.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15389763","citation_count":51,"is_preprint":false},{"pmid":"14755455","id":"PMC_14755455","title":"A dyslexia susceptibility locus (DYX7) linked to dopamine D4 receptor (DRD4) region on chromosome 11p15.5.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14755455","citation_count":49,"is_preprint":false},{"pmid":"17407504","id":"PMC_17407504","title":"Dopamine receptor genes (DRD2, DRD3 and DRD4) and gene-gene interactions associated with smoking-related behaviors.","date":"2007","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/17407504","citation_count":49,"is_preprint":false},{"pmid":"20644990","id":"PMC_20644990","title":"The dopamine receptor D4 gene (DRD4) moderates family environmental effects on ADHD.","date":"2011","source":"Journal of abnormal child psychology","url":"https://pubmed.ncbi.nlm.nih.gov/20644990","citation_count":48,"is_preprint":false},{"pmid":"24102377","id":"PMC_24102377","title":"Mothers' prenatal stress and their children's antisocial outcomes--a moderating role for the dopamine D4 receptor (DRD4) gene.","date":"2013","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/24102377","citation_count":48,"is_preprint":false},{"pmid":"16781678","id":"PMC_16781678","title":"Association between DRD4 gene and performance of children with ADHD in a test of sustained attention.","date":"2006","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16781678","citation_count":48,"is_preprint":false},{"pmid":"15211638","id":"PMC_15211638","title":"Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15211638","citation_count":48,"is_preprint":false},{"pmid":"15094785","id":"PMC_15094785","title":"Pedigree disequilibrium test (PDT) replicates association and linkage between DRD4 and ADHD in multigenerational and extended pedigrees from a genetic isolate.","date":"2004","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/15094785","citation_count":48,"is_preprint":false},{"pmid":"17474081","id":"PMC_17474081","title":"Novelty seeking and the dopamine D4 receptor gene (DRD4) revisited in Asians: haplotype characterization and relevance of the 2-repeat allele.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17474081","citation_count":48,"is_preprint":false},{"pmid":"17440932","id":"PMC_17440932","title":"Anorexia nervosa, perfectionism, and dopamine D4 receptor (DRD4).","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17440932","citation_count":47,"is_preprint":false},{"pmid":"15048658","id":"PMC_15048658","title":"Human personality dimensions of persistence and harm avoidance associated with DRD4 and 5-HTTLPR polymorphisms.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15048658","citation_count":47,"is_preprint":false},{"pmid":"12860355","id":"PMC_12860355","title":"Polymorphisms of DRD4 and DRD3 and risk of avoidant and obsessive personality traits and disorders.","date":"2003","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/12860355","citation_count":46,"is_preprint":false},{"pmid":"25933062","id":"PMC_25933062","title":"Combined epigenetic and intraspecific variation of the DRD4 and SERT genes influence novelty seeking behavior in great tit Parus major.","date":"2015","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/25933062","citation_count":43,"is_preprint":false},{"pmid":"21207241","id":"PMC_21207241","title":"A family based association study of DRD4, DAT1, and 5HTT and continuous traits of attention-deficit hyperactivity disorder.","date":"2011","source":"Behavior genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21207241","citation_count":42,"is_preprint":false},{"pmid":"23283341","id":"PMC_23283341","title":"DRD4 genotype predicts longevity in mouse and human.","date":"2013","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23283341","citation_count":41,"is_preprint":false},{"pmid":"23986684","id":"PMC_23986684","title":"The association between creativity and 7R polymorphism in the dopamine receptor D4 gene (DRD4).","date":"2013","source":"Frontiers in human neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23986684","citation_count":41,"is_preprint":false},{"pmid":"12192624","id":"PMC_12192624","title":"DRD4 promoter SNPs and gender effects on Extraversion in African Americans.","date":"2002","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/12192624","citation_count":41,"is_preprint":false},{"pmid":"16356184","id":"PMC_16356184","title":"Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains.","date":"2005","source":"Behavioral and brain functions : BBF","url":"https://pubmed.ncbi.nlm.nih.gov/16356184","citation_count":39,"is_preprint":false},{"pmid":"26897359","id":"PMC_26897359","title":"Epigenetic regulation of the DRD4 gene and dimensions of attention-deficit/hyperactivity disorder in children.","date":"2016","source":"European child & adolescent psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/26897359","citation_count":38,"is_preprint":false},{"pmid":"15389764","id":"PMC_15389764","title":"Multiple marker analysis at the promoter region of the DRD4 gene and ADHD: evidence of linkage and association with the SNP -616.","date":"2004","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/15389764","citation_count":38,"is_preprint":false},{"pmid":"23713429","id":"PMC_23713429","title":"DRD4 and TH gene polymorphisms are associated with activity, impulsivity and inattention in Siberian Husky dogs.","date":"2013","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23713429","citation_count":37,"is_preprint":false},{"pmid":"17508995","id":"PMC_17508995","title":"Polymorphisms of the dopamine D4 receptor gene (DRD4 VNTR) and cannabinoid CB1 receptor gene (CNR1) are not strongly related to cue-reactivity after alcohol exposure.","date":"2007","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/17508995","citation_count":36,"is_preprint":false},{"pmid":"24521003","id":"PMC_24521003","title":"Genetics of preparation and response control in ADHD: the role of DRD4 and DAT1.","date":"2014","source":"Journal of child psychology and psychiatry, and allied disciplines","url":"https://pubmed.ncbi.nlm.nih.gov/24521003","citation_count":35,"is_preprint":false},{"pmid":"20468066","id":"PMC_20468066","title":"The DRD4 receptor Exon 3 VNTR and 5' SNP variants and mRNA expression in human post-mortem brain tissue.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20468066","citation_count":35,"is_preprint":false},{"pmid":"11966444","id":"PMC_11966444","title":"Noninvasive genotyping of dopamine receptor D4 (DRD4) using nanograms of DNA from substance-dependent patients.","date":"2002","source":"Current medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11966444","citation_count":35,"is_preprint":false},{"pmid":"12223255","id":"PMC_12223255","title":"Ethnic heterogeneity in allele variation in the DRD4 gene in schizophrenia.","date":"2002","source":"Schizophrenia research","url":"https://pubmed.ncbi.nlm.nih.gov/12223255","citation_count":35,"is_preprint":false},{"pmid":"23314010","id":"PMC_23314010","title":"DRD4 and striatal modulation of the link between childhood behavioral inhibition and adolescent anxiety.","date":"2013","source":"Social cognitive and affective neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23314010","citation_count":33,"is_preprint":false},{"pmid":"19482058","id":"PMC_19482058","title":"Thyroid hormone and adrenergic signaling interact to control pineal expression of the dopamine receptor D4 gene (Drd4).","date":"2009","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19482058","citation_count":33,"is_preprint":false},{"pmid":"19493320","id":"PMC_19493320","title":"Linking gene, brain, and behavior: DRD4, frontal asymmetry, and temperament.","date":"2009","source":"Psychological science","url":"https://pubmed.ncbi.nlm.nih.gov/19493320","citation_count":32,"is_preprint":false},{"pmid":"23127570","id":"PMC_23127570","title":"DRD4 gene and obsessive compulsive disorder: do symptom dimensions have specific genetic correlates?","date":"2012","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23127570","citation_count":32,"is_preprint":false},{"pmid":"11054768","id":"PMC_11054768","title":"Association analysis of polymorphisms in the DRD4 gene and heroin abuse in Chinese subjects.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11054768","citation_count":32,"is_preprint":false},{"pmid":"32075956","id":"PMC_32075956","title":"DRD4 48 bp multiallelic variants as age-population-specific biomarkers in attention-deficit/hyperactivity disorder.","date":"2020","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/32075956","citation_count":31,"is_preprint":false},{"pmid":"24153108","id":"PMC_24153108","title":"Association between the seven-repeat allele of the dopamine-4 receptor gene (DRD4) and spontaneous food intake in pre-school children.","date":"2013","source":"Appetite","url":"https://pubmed.ncbi.nlm.nih.gov/24153108","citation_count":30,"is_preprint":false},{"pmid":"16472910","id":"PMC_16472910","title":"Association between dopamine D4 receptor (DRD4) exon III polymorphism and Neuroticism in the Japanese population.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16472910","citation_count":29,"is_preprint":false},{"pmid":"11324944","id":"PMC_11324944","title":"The DRD4 gene and the spiritual transcendence scale of the character temperament index.","date":"2000","source":"Psychiatric genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11324944","citation_count":29,"is_preprint":false},{"pmid":"22617852","id":"PMC_22617852","title":"COMT x DRD4 epistasis impacts prefrontal cortex function underlying response control.","date":"2012","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/22617852","citation_count":29,"is_preprint":false},{"pmid":"21615938","id":"PMC_21615938","title":"Genetic polymorphisms in folate pathway enzymes, DRD4 and GSTM1 are related to temporomandibular disorder.","date":"2011","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21615938","citation_count":28,"is_preprint":false},{"pmid":"19146920","id":"PMC_19146920","title":"Genetic interaction analysis for DRD4 and DAT1 genes in a group of Mexican ADHD patients.","date":"2009","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/19146920","citation_count":27,"is_preprint":false},{"pmid":"16165273","id":"PMC_16165273","title":"Family-based association study of DAT1 and DRD4 polymorphism in Korean children with ADHD.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16165273","citation_count":27,"is_preprint":false},{"pmid":"38354631","id":"PMC_38354631","title":"DRD4 alleviates acute kidney injury by suppressing ISG15/NOX4 axis-associated oxidative stress.","date":"2024","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/38354631","citation_count":26,"is_preprint":false},{"pmid":"26439067","id":"PMC_26439067","title":"The interplay of birth weight, dopamine receptor D4 gene (DRD4), and early maternal care in the prediction of disorganized attachment at 36 months of age.","date":"2015","source":"Development and psychopathology","url":"https://pubmed.ncbi.nlm.nih.gov/26439067","citation_count":26,"is_preprint":false},{"pmid":"21286365","id":"PMC_21286365","title":"Association between DRD4 genotype and Autistic Symptoms in DSM-IV ADHD.","date":"2011","source":"Journal of the Canadian Academy of Child and Adolescent Psychiatry = Journal de l'Academie canadienne de psychiatrie de l'enfant et de l'adolescent","url":"https://pubmed.ncbi.nlm.nih.gov/21286365","citation_count":26,"is_preprint":false},{"pmid":"29087970","id":"PMC_29087970","title":"Gene-gene interaction between DRD4 and COMT modulates clinical response to clozapine in treatment-resistant schizophrenia.","date":"2018","source":"Pharmacogenetics and genomics","url":"https://pubmed.ncbi.nlm.nih.gov/29087970","citation_count":25,"is_preprint":false},{"pmid":"28258362","id":"PMC_28258362","title":"The effects of GRIN2B and DRD4 gene variants on local functional connectivity in attention-deficit/hyperactivity disorder.","date":"2018","source":"Brain imaging and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/28258362","citation_count":23,"is_preprint":false},{"pmid":"26669286","id":"PMC_26669286","title":"Population differentiation and behavioural association of the two 'personality' genes DRD4 and SERT in dunnocks (Prunella modularis).","date":"2016","source":"Molecular ecology","url":"https://pubmed.ncbi.nlm.nih.gov/26669286","citation_count":23,"is_preprint":false},{"pmid":"22564179","id":"PMC_22564179","title":"Double dissociation between lab measures of inattention and impulsivity and the dopamine transporter gene (DAT1) and dopamine D4 receptor gene (DRD4).","date":"2012","source":"Journal of abnormal psychology","url":"https://pubmed.ncbi.nlm.nih.gov/22564179","citation_count":23,"is_preprint":false},{"pmid":"18063308","id":"PMC_18063308","title":"Association of DRD4 and COMT polymorphisms with anger and forgiveness traits in healthy volunteers.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/18063308","citation_count":22,"is_preprint":false},{"pmid":"23252368","id":"PMC_23252368","title":"The -521 C/T variant in the dopamine-4-receptor gene (DRD4) is associated with skiing and snowboarding behavior.","date":"2012","source":"Scandinavian journal of medicine & science in sports","url":"https://pubmed.ncbi.nlm.nih.gov/23252368","citation_count":22,"is_preprint":false},{"pmid":"22126256","id":"PMC_22126256","title":"Gene-environment interaction in problematic substance use: interaction between DRD4 and insecure attachments.","date":"2011","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/22126256","citation_count":21,"is_preprint":false},{"pmid":"23460366","id":"PMC_23460366","title":"Gene-environment interaction between DRD4 7-repeat VNTR and early child-care experiences predicts self-regulation abilities in prekindergarten.","date":"2013","source":"Developmental psychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23460366","citation_count":21,"is_preprint":false},{"pmid":"21595008","id":"PMC_21595008","title":"Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations.","date":"2011","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21595008","citation_count":20,"is_preprint":false},{"pmid":"20150884","id":"PMC_20150884","title":"Increased dopamine DRD4 receptor mRNA expression in lymphocytes of musicians and autistic individuals: bridging the music-autism connection.","date":"2010","source":"Neuro endocrinology letters","url":"https://pubmed.ncbi.nlm.nih.gov/20150884","citation_count":20,"is_preprint":false},{"pmid":"10898909","id":"PMC_10898909","title":"Investigation of dopamine receptor (DRD4) and dopamine transporter (DAT) polymorphisms for genetic linkage or association to panic disorder.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10898909","citation_count":20,"is_preprint":false},{"pmid":"21506030","id":"PMC_21506030","title":"DRD4 genotype moderates the impact of parental problems on unresolved loss or trauma.","date":"2011","source":"Attachment & human development","url":"https://pubmed.ncbi.nlm.nih.gov/21506030","citation_count":20,"is_preprint":false},{"pmid":"24834341","id":"PMC_24834341","title":"The relationship between DRD4 polymorphisms and phenotypic correlations of behaviors in the collared flycatcher.","date":"2014","source":"Ecology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/24834341","citation_count":20,"is_preprint":false},{"pmid":"29379288","id":"PMC_29379288","title":"A meta-analysis of data associating DRD4 gene polymorphisms with schizophrenia.","date":"2018","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/29379288","citation_count":19,"is_preprint":false},{"pmid":"16815339","id":"PMC_16815339","title":"Association between dopamine D4 receptor (DRD4) gene polymorphisms and novelty-elicited auditory event-related potentials in preschool children.","date":"2006","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/16815339","citation_count":19,"is_preprint":false},{"pmid":"28103253","id":"PMC_28103253","title":"Polymorphisms in HTR2A and DRD4 Predispose to Smoking and Smoking Quantity.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28103253","citation_count":18,"is_preprint":false},{"pmid":"15565493","id":"PMC_15565493","title":"DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents.","date":"2004","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/15565493","citation_count":18,"is_preprint":false},{"pmid":"23034259","id":"PMC_23034259","title":"Association analysis of dopaminergic gene variants (Comt, Drd4 And Dat1) with Alzheimer s disease.","date":"2012","source":"Journal of biological regulators and homeostatic agents","url":"https://pubmed.ncbi.nlm.nih.gov/23034259","citation_count":18,"is_preprint":false},{"pmid":"33584304","id":"PMC_33584304","title":"DRD4 Mitigates Myocardial Ischemia/Reperfusion Injury in Association With PI3K/AKT Mediated Glucose Metabolism.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/33584304","citation_count":18,"is_preprint":false},{"pmid":"31561595","id":"PMC_31561595","title":"A Novel Multi-Target Small Molecule, LCC-09, Inhibits Stemness and Therapy-Resistant Phenotypes of Glioblastoma Cells by Increasing miR-34a and Deregulating the DRD4/Akt/mTOR Signaling Axis.","date":"2019","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/31561595","citation_count":18,"is_preprint":false},{"pmid":"30364935","id":"PMC_30364935","title":"Cultural variation in the gray matter volume of the prefrontal cortex is moderated by the dopamine D4 receptor gene (DRD4).","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/30364935","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48725,"output_tokens":2199,"usd":0.08958,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9256,"output_tokens":2630,"usd":0.056015,"stage2_stop_reason":"end_turn"},"total_usd":0.145595,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1993,\n      \"finding\": \"The DRD4 gene contains a hypervariable segment within the third cytoplasmic loop of the protein, consisting of varying numbers of imperfect 48-bp direct repeats (2–10 repeat units) in exon 3. Alleles vary in both repeat number and sequence, producing 18 different predicted amino acid sequences, making this one of the most variable functional proteins described.\",\n      \"method\": \"PCR amplification and sequence analysis of 178 unrelated chromosomes; pharmacological characterization of allelic variants\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct DNA sequencing with pharmacological characterization, replicated across large population sample\",\n      \"pmids\": [\"8353495\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"A -521C>T polymorphism in the 5'-promoter region of DRD4 was identified; transient expression assays showed that the T allele reduces DRD4 transcriptional efficiency by approximately 40% compared with the C allele.\",\n      \"method\": \"Identification of novel SNP by sequencing; transient expression (reporter) assay measuring transcriptional efficiency\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro transcriptional assay in a single study, not independently replicated in this corpus\",\n      \"pmids\": [\"10329380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Pineal Drd4 expression shows a >100-fold circadian rhythm under photoneural control; the gene is expressed predominantly in pinealocytes and retina. Unlike most rhythmically expressed pineal genes controlled solely by adrenergic/cAMP signaling, Drd4 expression additionally requires thyroid hormone.\",\n      \"method\": \"mRNA quantification across tissues and time points in rat; pharmacological and photoneural manipulation (adrenergic signaling blockade, thyroid hormone manipulation)\",\n      \"journal\": \"Molecular and cellular endocrinology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo rat model with multiple pharmacological manipulations, single lab\",\n      \"pmids\": [\"19482058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"DRD4 activation (by agonist PD168077) in isolated rat hearts and cardiomyocytes subjected to ischemia/reperfusion injury reduced apoptosis, improved cardiac function, and increased membrane GLUT4 localization (without changing total GLUT4 protein). This protective effect was dependent on PI3K/AKT pathway activation; PI3K inhibitor (Wortmannin) blocked GLUT4 membrane translocation and reversed the cardioprotection.\",\n      \"method\": \"Langendorff ex vivo perfused rat heart I/R model; in vitro cardiomyocyte A/R model; DRD4 agonist (PD168077); Western blot for PI3K/AKT phosphorylation and GLUT4 localization; TUNEL staining; flow cytometry; PI3K inhibitor epistasis\",\n      \"journal\": \"Frontiers in pharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (ex vivo, in vitro, pharmacological epistasis), single lab\",\n      \"pmids\": [\"33584304\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DRD4 is decreased in kidneys during AKI (IRI or cisplatin model). DRD4 suppresses oxidative stress-induced AKI by downregulating ISG15 expression, which in turn suppresses NOX4 ISGylation; reduced ISGylation enhances ubiquitination and proteasomal degradation of NOX4, decreasing ROS production and mitochondrial damage. DRD4 overexpression ameliorates apoptosis in HK-2 cells.\",\n      \"method\": \"In vivo mouse IRI and cisplatin AKI models; in vitro HK-2 cell hypoxia/reoxygenation; transcriptome sequencing; Western blot for ISG15, NOX4, ubiquitination/ISGylation; ROS assays; DRD4 overexpression/knockdown\",\n      \"journal\": \"Redox biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (in vivo, in vitro, transcriptomics, biochemical pathway dissection), single lab\",\n      \"pmids\": [\"38354631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Meta-analytic and bioinformatics analysis established that the DRD4 4-repeat allele leads to higher receptor expression and increased sensitivity to dopamine compared with the 7-repeat allele, consistent with the 4R allele being protective and 7R being a risk factor for ADHD in European-Caucasian populations. The 7R allele was also linked to poorer methylphenidate efficacy.\",\n      \"method\": \"Meta-analysis of >3000 cases and >16,000 controls; bioinformatics analysis of receptor expression data comparing 4R vs. 7R allele functional differences\",\n      \"journal\": \"Translational psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — large meta-analysis integrating published functional and clinical data, but no new in vitro/in vivo mechanistic experiment\",\n      \"pmids\": [\"32075956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"DRD4 mRNA expression is significantly elevated in peripheral blood lymphocytes of both musicians and individuals with autistic spectrum disorder (ASD) compared to healthy controls, whereas DRD3 mRNA expression did not differ between groups.\",\n      \"method\": \"mRNA expression quantification by RT-PCR from peripheral blood lymphocytes in three groups (controls, musicians, ASD); ANOVA with post-hoc analysis\",\n      \"journal\": \"Neuro endocrinology letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single method (mRNA quantification in blood), no functional follow-up\",\n      \"pmids\": [\"20150884\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In TMZ-resistant glioblastoma cells, DRD4 expression is upregulated alongside Akt, mTOR, β-catenin, CDK6, NF-κB, and Erk1/2. Treatment with the novel compound LCC-09 downregulated DRD4 and these downstream signaling molecules, suppressed GSC stemness traits, and was associated with re-expression of tumor suppressor miR-34a, both in vitro and in vivo.\",\n      \"method\": \"GBM cell lines (U87MG, D54MG); Western blot for DRD4 and pathway markers; neurosphere formation; ALDH activity assay; in vivo xenograft model; miR-34a expression analysis\",\n      \"journal\": \"Cancers\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — DRD4 pathway placement is correlative/pharmacological (no DRD4-specific genetic manipulation), single lab\",\n      \"pmids\": [\"31561595\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DRD4 is a G protein-coupled dopamine receptor whose third cytoplasmic loop encodes a highly polymorphic 48-bp VNTR (2–10 repeats) that alters receptor amino acid sequence and function (with the 4-repeat allele conferring higher receptor expression and dopamine sensitivity than the 7-repeat allele); its promoter -521C>T SNP regulates transcriptional efficiency (~40% reduction for T allele); in the pineal gland its expression is driven by both adrenergic/cAMP and thyroid hormone signals in a circadian fashion; in the kidney DRD4 protects against acute injury by suppressing the ISG15–NOX4 ISGylation axis to reduce oxidative stress and apoptosis; and in the heart DRD4 activation promotes GLUT4 membrane translocation via PI3K/AKT signaling to confer cardioprotection against ischemia/reperfusion injury.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"DRD4 is a G protein-coupled dopamine receptor distinguished by an extraordinarily polymorphic third cytoplasmic loop, where exon 3 carries a hypervariable 48-bp VNTR (2–10 repeat units) that generates at least 18 distinct receptor amino acid sequences, making it one of the most variable functional human proteins described [#0]. This coding variation has functional consequences: the 4-repeat allele confers higher receptor expression and greater dopamine sensitivity than the 7-repeat allele, with allelic differences linked to ADHD risk and methylphenidate response in European-Caucasian populations [#5]. Receptor abundance is further tuned at the transcriptional level by a -521C>T promoter polymorphism, where the T allele reduces transcriptional efficiency by roughly 40% [#1]. DRD4 expression is itself dynamically regulated: in the pineal gland it shows a >100-fold circadian rhythm under photoneural control and, unusually, requires thyroid hormone in addition to the adrenergic/cAMP signaling that drives most rhythmic pineal genes [#2]. Beyond the nervous system, DRD4 signaling is cytoprotective in peripheral tissues: in ischemic/reperfused heart, agonist activation drives GLUT4 membrane translocation through PI3K/AKT signaling to limit cardiomyocyte apoptosis [#3], and in the kidney it suppresses oxidative-stress-induced acute injury by downregulating ISG15 to reduce NOX4 ISGylation, thereby promoting NOX4 ubiquitination and proteasomal degradation and lowering ROS [#4].\",\n  \"teleology\": [\n    {\n      \"year\": 1993,\n      \"claim\": \"Established that DRD4 harbors an unprecedented coding polymorphism, defining the molecular basis for functional receptor heterogeneity in the population.\",\n      \"evidence\": \"PCR amplification and sequencing of 178 chromosomes with pharmacological characterization of allelic variants\",\n      \"pmids\": [\"8353495\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish how individual repeat numbers alter G-protein coupling or downstream signaling output\", \"Functional consequences of specific sequence variants not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified a promoter SNP controlling DRD4 transcription, showing receptor dosage is regulated upstream of coding variation.\",\n      \"evidence\": \"Novel SNP identification by sequencing and transient reporter expression assay\",\n      \"pmids\": [\"10329380\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro reporter assay not replicated in this corpus\", \"Transcription factor binding mediating the -521C>T effect not identified\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed dual hormonal control of DRD4 expression, distinguishing it from canonically cAMP-driven pineal genes by adding a thyroid hormone requirement.\",\n      \"evidence\": \"mRNA quantification across rat tissues/timepoints with adrenergic blockade and thyroid hormone manipulation\",\n      \"pmids\": [\"19482058\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular mechanism linking thyroid hormone to Drd4 transcription not defined\", \"Functional role of circadian DRD4 in pinealocytes/retina not established\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Correlated peripheral DRD4 expression with behavioral phenotypes, but without mechanistic linkage.\",\n      \"evidence\": \"RT-PCR mRNA quantification in blood lymphocytes from controls, musicians, and ASD individuals\",\n      \"pmids\": [\"20150884\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Single method (blood mRNA) with no functional follow-up\", \"No causal link between lymphocyte DRD4 levels and phenotype\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Placed DRD4 in a glioblastoma stemness signaling network, though only by correlation.\",\n      \"evidence\": \"GBM cell lines and xenograft with Western blot, neurosphere and ALDH assays following LCC-09 treatment\",\n      \"pmids\": [\"31561595\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"DRD4 pathway placement is pharmacological/correlative without DRD4-specific genetic manipulation\", \"Direct role of DRD4 versus co-regulated effectors not separated\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Quantified the functional difference between 4R and 7R alleles, connecting receptor expression/dopamine sensitivity to disease risk and drug response.\",\n      \"evidence\": \"Meta-analysis of >3000 cases/>16000 controls with bioinformatic comparison of allele expression\",\n      \"pmids\": [\"32075956\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No new in vitro/in vivo mechanistic experiment\", \"Causal molecular basis for differential dopamine sensitivity not directly tested\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined a cardioprotective signaling output for DRD4, linking receptor activation to glucose transporter trafficking via PI3K/AKT.\",\n      \"evidence\": \"Langendorff ex vivo heart and cardiomyocyte I/R models with PD168077 agonist and Wortmannin epistasis, GLUT4 and phospho-AKT Western blots\",\n      \"pmids\": [\"33584304\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single lab; G-protein coupling upstream of PI3K not delineated\", \"In vivo cardioprotection in whole animals not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Established a renal cytoprotective mechanism, mapping DRD4 to suppression of the ISG15–NOX4 ISGylation axis and consequent ROS reduction.\",\n      \"evidence\": \"Mouse IRI/cisplatin AKI and HK-2 hypoxia/reoxygenation models with transcriptomics, ISGylation/ubiquitination Western blots, ROS assays, DRD4 overexpression/knockdown\",\n      \"pmids\": [\"38354631\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking DRD4 signaling to ISG15 downregulation not resolved\", \"Single lab; receptor-proximal signaling steps undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the coding VNTR and promoter variants mechanistically translate into differential downstream signaling, and whether the cardiac and renal cytoprotective pathways generalize, remains open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural/biochemical link between repeat number and G-protein coupling efficiency\", \"Receptor-proximal signaling steps in heart and kidney not defined\", \"Common molecular logic across tissues not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 3]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}